Are you Christopher S. Dakhil, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileWhere to find Christopher S. Dakhil, M.D.
- Wichita location main office
818 N Emporia St Ste 403, Wichita, KS 67214 - Dodge City location
116 W Ross Blvd, Dodge City, KS 67801 - Winfield location
1305 E 5th Ave, Winfield, KS 67156 - Pratt location
124 Commodore St Ste A, Pratt, KS 67124 - Wellington location
507 E 16th St, Wellington, KS 67152
About Dr. Dakhil
Christopher S. Dakhil, M.D. practices hematology & oncology in Wichita, KS. Christopher is a 2006 graduate of University of Kansas School of Med (Kc/Wich/Sal). Christopher is also listed as specializing in internal medicine. According to Medicare claims data, Christopher cared for 1,195 Medicare patients across 352,015 services. The services billed most often include injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram, injection, pembrolizumab, 1 mg, and injection, nivolumab, 1 mg. The provider's National Provider Identifier (NPI) is 1972721348.
Factual summary compiled by Guide.md from public records; not written by this provider.
Education & Training
Specialty
Credentials & Licensing
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (316) 262-4467
- Email not available
Practice Locations
818 N EMPORIA ST STE 403
Wichita, KS 67214
116 W Ross Blvd
Dodge City, KS 67801
1305 E 5th Ave
Winfield, KS 67156
124 Commodore St Ste A
Pratt, KS 67124
507 E 16th St
Wellington, KS 67152
Conditions Commonly Evaluated or Treated
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Advanced Cancers
Blood & Lymph Disorders
Blood Cancers
Blood Disorders
- Bleeding Disorders
- Blood Clot in Lung
- Blood Clotting Gene Mutation
- Deep vein thrombosis
- Hemochromatosis
- High Platelet Count
- High White Blood Cell Count
- Low Platelets
- Low White Blood Cell Count
- Thick Blood
- Unexplained Bruising
Blood disorders
- Bone Marrow Scarring
- Hemolytic Anemia in Children
- Pre-Myeloma Protein In Blood
- Vitamin B12 deficiency anemia
Bone & Soft Tissue Cancers
Digestive Cancers
Endocrine Cancers
Endocrine tumors
Gastrointestinal cancer
General oncology
Genetic Blood Disorders
Gynecologic cancer
Gynecologic Cancers
Head & Neck Cancers
Head and neck cancer
Neurologic Cancers
Oncologic emergencies
Ophthalmologic oncology
Skin cancer
Skin Cancers
Urologic Cancers
Procedures & services
Biopsies & Diagnostics
Cancer care
Pain & wellness
Most searched procedures
Blood disorder care
Cancer Therapies
Cancer therapy
- Chemo allergy desensitization
- Oral chemotherapy management
- Radiation oncology consultation
- Spinal chemo injection
Cellular Therapies
Consultations
Diagnostic testing
Hematology Treatments
Imaging
Infusions
Interventional oncology
Supportive Cancer Care
- Bone Strengthening Injections For Cancer
- Pain Management For Cancer
- Red Blood Cell Booster Shot
- White Blood Cell Booster Injection
Supportive cancer care
- Cancer nutrition counseling
- Chemo brain treatment
- Cold cap therapy for hair loss
- Fertility Preservation for Teens Before Cancer Treatment
- Hyperbaric oxygen for radiation damage
- Lymphedema Drainage Therapy
- Palliative cancer care
Surgical & Vascular Access
- Chemo port placement
- Chemo port removal
- Draining lung fluid
- Paracentesis
- PICC line placement coordination
Testing & Genetics
Vascular access care
Procedures Most Often Billed to Medicare
352,015 services · 1,195 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
44,200 | More than most peers in Hematology & Oncology |
| Injection, nivolumab, 1 mg | Drug given | J9299 |
33,280 | More often than most peers in Hematology & Oncology |
| Injection, aprepitant, 1 mg | Drug given | J0185 |
31,330 | More than most peers in Hematology & Oncology |
| Injection, oxaliplatin, 0.5 mg | Drug given | J9263 |
28,664 | More than most peers in Hematology & Oncology |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | Drug given | J9144 |
25,560 | More than most peers in Hematology & Oncology |
| Injection, granisetron, extended-release, 0.1 mg | Drug given | J1627 |
18,800 | More often than most peers in Hematology & Oncology |
| Injection, ferric carboxymaltose, 1 mg | Drug given | J1439 |
18,750 | Less often than most peers in Hematology & Oncology |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
16,760 | As often as other peers in Hematology & Oncology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
16,380 | More than most peers in Hematology & Oncology |
| Injection, lanreotide, 1 mg | Drug given | J1930 |
11,640 | More than most peers in Hematology & Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Other cancer specialists at this location 2
Same specialty, same street address — most likely the same department or group.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
Other cancer specialists in Wichita 6
Same specialty, same city.
More connections — 15 related providers in 2 groups
Trained at University of Kansas School of Med (Kc/Wich/Sal) 7
Other providers in the same specialty who trained at the same institution.
Class of 2006 at University of Kansas School of Med (Kc/Wich/Sal) 8
Providers who graduated from the same medical school in the same year.
Common questions
What kind of doctor is Christopher S. Dakhil?
Christopher S. Dakhil is a cancer specialist in Wichita, KS. That is the designation recorded for this NPI in the federal registry, where it is listed as “Hematology & Oncology”.
NPI registry
What is Christopher S. Dakhil's address?
Christopher S. Dakhil is listed at 818 N Emporia St Ste 403, Wichita, KS 67214. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
How can I make an appointment with Christopher S. Dakhil?
The number on file is (316) 262-4467. Contact the office directly to confirm availability and scheduling.
NPI registry
What is Christopher S. Dakhil's NPI number?
Christopher S. Dakhil's National Provider Identifier is 1972721348. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Where did Christopher S. Dakhil train?
Christopher S. Dakhil attended University of Kansas School of Med (Kc/Wich/Sal), graduating in 2006. This comes from the CMS National Downloadable File.
CMS public data
How long has Christopher S. Dakhil been practicing?
Christopher S. Dakhil has 20 years experience. Calculated from a graduation year of 2006, reported in the CMS National Downloadable File.
CMS public data
What procedures does Christopher S. Dakhil perform?
According to Medicare billing data, Christopher S. Dakhil the Medicare record under this individual NPI shows mainly office visits and diagnostic testing. Hospital-based physicians usually have their procedural work billed by the facility rather than under their own number, so this is a floor on their practice, not a description of it. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Has Christopher S. Dakhil confirmed this information?
Not yet. This profile is built from public federal data and has not been confirmed by Christopher S. Dakhil. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.